Improved antitumoral treatments

Details Improved antitumoral treatments Improved antitumoral treatments

A - Human Necessities

61

K

A61K 38/15 (2006.01) A61K 31/282 (2006.01) A61K 31/337 (2006.01) A61K 31/404 (2006.01) A61K 31/436 (2006.01) A61K 31/495 (2006.01) A61K 31/505 (2006.01) A61K 31/7068 (2006.01) A61K 33/24 (2006.01)

Patent

CA 2717117

The present invention relates to combinations of PM02734 with another anticancer drug selected from Cisplatin, Gemcitabine, Paclitaxel, Oxaliplatin, 5-Fluorouracil, Trabectedin, Rapamycin, and Sunitinib, and the use of these combinations in the treatment of cancer.

La présente invention porte sur des combinaisons de PM02734 avec un autre médicament anticancéreux choisi parmi le cisplatine, la gemcitabine, le paclitaxel, l'oxaliplatine, le 5-fluorouracile, la trabectédine, la rapamycine et le sunitinib, et sur l'utilisation de ces combinaisons dans le traitement du cancer.

Affiliated with

Also associated with

Rating

Improved antitumoral treatments does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved antitumoral treatments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved antitumoral treatments will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2091569